Skip to main content
Top

Subcutaneous or Intravenous Abatacept Monotherapy in Pediatric Patients with Polyarticular-Course JIA: Results from Two Phase III Trials

print
PRINT
insite
SEARCH

Monday, November 11, 15:15–15:30. Georgia World Congress Center, Atlanta, USA

Presenting author: Nicolino Ruperto, Italy

What our Editorial Board said:

This trial is of interest to pediatric rheumatologists because it shows that abatacept can be used effectively with or without concomitant methotrexate. This suggests that children may not need to be treated with both methotrexate and abatacept in order to have disease control.


– Sangeeta Sule, USA

Back to the ACR/ARP 2019 conference hub

print
PRINT